142 related articles for article (PubMed ID: 27002825)
1. Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with Cyclophosphamide.
Audemard-Verger A; Martin Silva N; Verstuyft C; Costedoat-Chalumeau N; Hummel A; Le Guern V; Sacré K; Meyer O; Daugas E; Goujard C; Sultan A; Lobbedez T; Galicier L; Pourrat J; Le Hello C; Godin M; Morello R; Lambert M; Hachulla E; Vanhille P; Queffeulou G; Potier J; Dion JJ; Bataille P; Chauveau D; Moulis G; Farge-Bancel D; Duhaut P; Saint-Marcoux B; Deroux A; Manuzak J; Francès C; Aumaitre O; Bezanahary H; Becquemont L; Bienvenu B
PLoS One; 2016; 11(3):e0151696. PubMed ID: 27002825
[TBL] [Abstract][Full Text] [Related]
2. Epistatic interactions among CYP2C19*2, CYP3A4 and GSTP1 on the cyclophosphamide therapy in lupus nephritis patients.
Kumaraswami K; Katkam SK; Aggarwal A; Sharma A; Manthri R; Kutala VK; Rajasekhar L
Pharmacogenomics; 2017 Oct; 18(15):1401-1411. PubMed ID: 28976264
[TBL] [Abstract][Full Text] [Related]
3. Influence of glutathione S transferase A1 gene polymorphism (-69C > T, rs3957356) on intravenous cyclophosphamide efficacy and side effects: a case-control study in Egyptian patients with lupus nephritis.
Attia DHS; Eissa M; Samy LA; Khattab RA
Clin Rheumatol; 2021 Feb; 40(2):753-762. PubMed ID: 32661806
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 polymorphisms and the response of lupus nephritis to cyclophosphamide therapy.
Winoto J; Song H; Hines C; Nagaraja H; Rovin BH
Clin Nephrol; 2011 May; 75(5):451-7. PubMed ID: 21543025
[TBL] [Abstract][Full Text] [Related]
5. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
6. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of glutathione S-transferase genotyping in patients with diffuse large B-cell lymphoma.
Atanaskovic L; Cikota-Aleksic B; Tarabar O; Trimcev J; Zivanovic-Ivic A; Marjanovic S; Magic Z
J BUON; 2016; 21(6):1459-1465. PubMed ID: 28039708
[TBL] [Abstract][Full Text] [Related]
8. Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese.
Zhong SL; Zhou SF; Chen X; Chan SY; Chan E; Ng KY; Duan W; Huang M
Eur J Pharm Sci; 2006 May; 28(1-2):77-85. PubMed ID: 16488119
[TBL] [Abstract][Full Text] [Related]
9. Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran.
Safarinejad MR; Shafiei N; Safarinejad SH
Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):105-13. PubMed ID: 21243008
[TBL] [Abstract][Full Text] [Related]
10. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
[TBL] [Abstract][Full Text] [Related]
11. The association of glutathione-S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) with idiopathic male infertility.
Safarinejad MR; Shafiei N; Safarinejad S
J Hum Genet; 2010 Sep; 55(9):565-70. PubMed ID: 20505681
[TBL] [Abstract][Full Text] [Related]
12. GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response.
Weich N; Ferri C; Moiraghi B; Bengió R; Giere I; Pavlovsky C; Larripa IB; Fundia AF
Cancer Epidemiol; 2016 Oct; 44():16-21. PubMed ID: 27454607
[TBL] [Abstract][Full Text] [Related]
13. Relation between glutathione S-transferase genes (GSTM1, GSTT1, and GSTP1) polymorphisms and clinical manifestations of sickle cell disease in Egyptian patients.
Ellithy HN; Yousri S; Shahin GH
Hematology; 2015 Dec; 20(10):598-606. PubMed ID: 25880856
[TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans.
Martínez C; Martín F; Fernández JM; García-Martín E; Sastre J; Díaz-Rubio M; Agúndez JA; Ladero JM
Pharmacogenomics; 2006 Jul; 7(5):711-8. PubMed ID: 16886896
[TBL] [Abstract][Full Text] [Related]
15. Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype.
García-González MA; Quintero E; Bujanda L; Nicolás D; Benito R; Strunk M; Santolaria S; Sopeña F; Badía M; Hijona E; Pérez-Aísa MA; Méndez-Sánchez IM; Thomson C; Carrera P; Piazuelo E; Jiménez P; Espinel J; Campo R; Manzano M; Geijo F; Pellisé M; González-Huix F; Espinós J; Titó L; Zaballa M; Pazo R; Lanas A
Mutagenesis; 2012 Nov; 27(6):771-7. PubMed ID: 22952149
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy.
Funke S; Timofeeva M; Risch A; Hoffmeister M; Stegmaier C; Seiler CM; Brenner H; Chang-Claude J
Pharmacogenomics; 2010 Jan; 11(1):33-41. PubMed ID: 20017670
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis.
Takada K; Arefayene M; Desta Z; Yarboro CH; Boumpas DT; Balow JE; Flockhart DA; Illei GG
Arthritis Rheum; 2004 Jul; 50(7):2202-10. PubMed ID: 15248218
[TBL] [Abstract][Full Text] [Related]
18. Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus.
Zhong S; Huang M; Yang X; Liang L; Wang Y; Romkes M; Duan W; Chan E; Zhou SF
Br J Clin Pharmacol; 2006 Oct; 62(4):457-72. PubMed ID: 16995867
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase T1, M1 and P1 Genetic Polymorphisms and Susceptibility to Colorectal Cancer in Turkey.
Gorukmez O; Yakut T; Gorukmez O; Sag SO; Topak A; Sahinturk S; Kanat O
Asian Pac J Cancer Prev; 2016; 17(8):3855-9. PubMed ID: 27644629
[TBL] [Abstract][Full Text] [Related]
20. Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.
Ekhart C; Doodeman VD; Rodenhuis S; Smits PH; Beijnen JH; Huitema AD
Pharmacogenet Genomics; 2008 Jun; 18(6):515-23. PubMed ID: 18496131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]